eEF2K activity determines synergy to co-treatment of cancer cells with PI3K and MEK inhibitors
Published: 9 July 2021| Version 1 | DOI: 10.17632/xjsdxnpxkb.1
Contributor:
Maruan Hijazi VegaDescription
Original data from Western blots
Files
Institutions
Barts Cancer Institute
Categories
Western Blot